Immunocytochemical staining patterns for parathyroid hormone and chromogranin in parathyroid hyperplasia, adenoma, and carcinoma
- PMID: 27519218
- DOI: 10.1007/BF02739826
Immunocytochemical staining patterns for parathyroid hormone and chromogranin in parathyroid hyperplasia, adenoma, and carcinoma
Abstract
Parathyroid glands (PGs) contain less secretory granules with presumably less stored parathyroid hormone (PTH) than many other endocrine glands. Immunocytochemical staining for PTH has been hindered by the lack of commercially available, reliable antibodies against human PTH. By treating deparaffinized tissue sections with an antigen-retrieval procedure, immunocytochemical staining for PTH and chromogranin A (CHA) was performed using commercially available monoclonal antibodies to investigate the functional activity of hyperfunctioning PGs, including chief cell hyperplasia (CCH), adenoma, and carcinoma, compared with that of normal PGs. In normal PGs, PTH and CHA immunostaining was diffusely granular in the chief cell cytoplasm, but was weak in oxyphil cells. The immunostaining in hyperfunctioning PGs was less dense in CCH, and adenomas were less intensely stained than the densely stained peripherally located normal rim. The one carcinoma case studied showed less staining at the periphery and in the mid-portion of the tumor. Thus, immunocytochemical staining for PTH and CHA provides further information on stored, immunoreactive PTH status and will improve functional analysis of hyperfunctioning parathyroid glands.
Keywords: Parathyroid glands; adenomas and carcinoma; chief cell hyperplasia; chromogranin; hyperparathyroidism; immunocytochemistry; parathyroid hormone.
Similar articles
-
Monoclonal/polyclonal PAX-8, PTH and GATA3 immunohistochemistry in parathyroid lesions.J Endocrinol Invest. 2021 Sep;44(9):1997-2008. doi: 10.1007/s40618-021-01518-3. Epub 2021 Feb 10. J Endocrinol Invest. 2021. PMID: 33566340
-
Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.Virchows Arch A Pathol Anat Histopathol. 1991;418(4):295-9. doi: 10.1007/BF01600157. Virchows Arch A Pathol Anat Histopathol. 1991. PMID: 2024450
-
Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.Pathol Res Pract. 2003;199(2):93-9. doi: 10.1078/0344-0338-00360. Pathol Res Pract. 2003. PMID: 12747471
-
Radionuclide imaging of the parathyroid glands.Semin Nucl Med. 2005 Oct;35(4):266-76. doi: 10.1053/j.semnuclmed.2005.06.001. Semin Nucl Med. 2005. PMID: 16150247 Review.
-
Primary hyperparathyroidism. A surgical perspective.Endocrinol Metab Clin North Am. 1989 Sep;18(3):701-14. Endocrinol Metab Clin North Am. 1989. PMID: 2673768 Review.
Cited by
-
Immunocytochemical localization of prohormone convertase 1/3 and 2 in gastrointestinal carcinoids.Endocr Pathol. 2001 Summer;12(2):137-45. doi: 10.1385/ep:12:2:137. Endocr Pathol. 2001. PMID: 11579679
-
Whole-body analysis of TRPML3 (MCOLN3) expression using a GFP-reporter mouse model reveals widespread expression in secretory cells and endocrine glands.PLoS One. 2022 Dec 15;17(12):e0278848. doi: 10.1371/journal.pone.0278848. eCollection 2022. PLoS One. 2022. PMID: 36520788 Free PMC article.
-
Immunohistochemistry in Diagnostic Parathyroid Pathology.Endocr Pathol. 2018 Jun;29(2):113-129. doi: 10.1007/s12022-018-9527-6. Endocr Pathol. 2018. PMID: 29626276 Review.
-
Two Cases of Metastatic Parathyroid Carcinoma in Male C3H Mice Following Irradiation.J Toxicol Pathol. 2013 Dec;26(4):413-7. doi: 10.1293/tox.2013-0018. Epub 2013 Dec 26. J Toxicol Pathol. 2013. PMID: 24526814 Free PMC article.
-
Diffuse parathyroid hormone expression in parathyroid tumors argues against important functional tumor subclones.Eur J Endocrinol. 2016 May;174(5):583-90. doi: 10.1530/EJE-15-1062. Epub 2016 Feb 10. Eur J Endocrinol. 2016. PMID: 26865585 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials